safety and efficacy studies towards the development of carbon nanostructure-based multimodal MRI-CT contrast agents.
No takes yet. Share an insight, caveat, or question.
Lalwani et al. (2014) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: